As a unique cancer clinical and translational research platform, EORTC occupies a strategic position in Europe. To address the multidisciplinarity of oncology in a complex regulatory environment, EORTC has created a complete clinical research infrastructure which builds on its internal and external expertise through mutually-beneficial partnerships to develop knowledge and advance therapeutic progress.
EORTC engages strategically with other stakeholders who share EORTC’s objectives to improve survival rates and quality of life for patients with cancer. EORTC promotes a partnership model where each stakeholder lends its expertise with clearly-defined responsibilities and a well-established infrastructure, while adhering to our principles of independence and quality.
EORTC partners include:
- academic networks,
- professional societies,
- patient advocacy groups,
- cancer leagues,
- government organisations,
- members of the healthcare industry.